20.586[J] Science and Business of Biotechnology (New)
Covers the new types of drugs and other therapeutics in current practice and under development, the financing and business structures of early-stage biotechnology companies, and the evaluation of their risk/reward profiles. Includes a series of live case studies with industry leaders of both established and emerging biotechnology companies as guest speakers, focusing on the underlying science and engineering as well as core financing and business issues. Students must possess a basic background in cellular and molecular biology.
This class has 15.401 as a prerequisite.
This class counts for a total of 9 credits. This is a graduate-level class.
You can find more information at the http://www.google.com/search?&q=MIT+%2B+20.586&btnG=Google+Search&inurl=https site.
© Copyright 2015 Yasyf Mohamedali